The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2024 Unbound Medicine, Inc. All rights reserved